Nevro Corp and Boston Scientific have reached an $85 million settlement in ongoing litigation over a spinal tech patent infringement.
The litigation is related to high-frequency spinal cord stimulation technology for pain relief.
Boston Scientific will pay Nevro $85 million, and in return, will receive a license to practice paresthesia-free therapy at frequencies below 1,500Hz, according to an Aug. 1 press release.
Boston Scientific will also give Nevro a license to use features from its family of patents.
This settlement concludes all ongoing litigation between the two parties.